Spire Wealth Management - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 32 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$162,000
+2.5%
148,8000.0%0.01%
+75.0%
Q1 2022$158,000
+39.8%
148,800
+18.3%
0.00%
+33.3%
Q4 2021$113,000
+370.8%
125,800
+598.9%
0.00%
+200.0%
Q3 2021$24,000
-11.1%
18,000
+28.6%
0.00%0.0%
Q2 2021$27,000
+200.0%
14,000
+600.0%
0.00%
Q1 2021$9,0002,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Spire Wealth Management 148,800$158,0000.00%
MEITAV INVESTMENT HOUSE LTD 244,332$257,0000.00%
Phoenix Holdings Ltd. 244,113$259,0000.00%
IHT Wealth Management, LLC 24,000$25,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Virtu Financial LLC 15,199$16,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,574$44,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,790$31,0000.00%
BANK OF AMERICA CORP /DE/ 5,153$5,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders